Skip to main content
. Author manuscript; available in PMC: 2021 May 7.
Published in final edited form as: Ocul Immunol Inflamm. 2020 Mar 6;29(2):244–249. doi: 10.1080/09273948.2019.1705985

Table 2.

AA GWAS analysis suggests OS-specific risk alleles.

Characteristics AA OS v HC AA CC AA OS v NOS
CHR BP SNP Gene Minor Allele OR 95% CIs P OR 95% CIs P OR 95% CIs P
3 65690367 rs1499506 MAGI1 C 0.51 0.40–0.64 1.2×10^−8 0.89 0.79–1.00 4.7×10^−2 0.49 0.38–0.64 9.1×10^−8
3 65690647 rs4437178 MAGI1 T 0.51 0.40–0.64 1.2×10^−8 0.89 0.79–1.00 4.1×10^−2 0.49 0.38–0.64 1.4×10^−7
3 65690975 rs59337986 MAGI1 CA 0.51 0.40–0.64 1.2×10^−8 0.89 0.79–1.00 4.1×10^−2 0.49 0.38–0.64 1.4×10^−7
3 65691043 rs17073522 MAGI1 G 0.51 0.40–0.64 1.2×10^−8 0.89 0.79–1.00 4.1×10^−2 0.49 0.38–0.64 1.4×10^−7
3 65691280 rs7618480 MAGI1 T 0.51 0.40–0.64 1.2×10^−8 0.89 0.79–1.00 4.1×10^−2 0.49 0.38–0.64 1.4×10^−7
3 65691371 rs7640824 MAGI1 A 0.51 0.41–0.65 2.3×10^−8 0.90 0.80–1.01 6.1×10^−2 0.49 0.38–0.64 1.5×10^−7
3 65692374 rs17073533 MAGI1 G 0.51 0.41–0.65 1.3×10^−8 0.90 0.80–1.01 6.1×10^−2 0.50 0.39–0.64 8.3×10^−8
18 14184043 rs4101176 ANKRD20A5P A 2.55 1.83–3.57 4.3×10^−8 1.35 1.07–1.70 1.1×10^−2 2.05 1.36–3.09 6.5×10^−4
18 14186391 rs543143 ANKRD20A5P C 2.53 1.89–3.38 5.2×10^−10 1.41 1.17–1.71 4.3×10^−4 1.93 1.36–2.74 2.33×10^−4
20 29650348 rs138887197 FRG1BP T 1.86 1.50–2.30 1.2×10^−8 1.25 1.10–1.41 6.5×10^−4 1.72 1.32–2.24 6.25×10^−5
22 48727259 rs133666 NA G 1.79 1.45–2.20 3.4×10^−8 1.17 1.03–1.33 1.8×10^−2 1.90 1.47–2.45 1.08×10^−6

To be defined as an OS-specific SNP, the variant had to be significant (p<5×10−8) in OS compared to controls. Known characteristics of each variant are included: chromosome (CHR), base pair (BP), reference SNP (SNP), and closest gene. Bolded p values indicate genome-wide significance. Italicized p values indicate that to achieve convergence, the association was calculated by PLINK. OR: Odds Ratio. CIs: confidence intervals. HC: healthy control. CC: case-control. NOS: non-OS.